Yale University
Findings support smaller, weight-adjusted dose of heparin for some patients
Published in Law and Health Weekly, October 16th, 2004
According to research published in the American Journal of Cardiology, "We investigated the effect of smaller dose, weight-adjusted heparin with earlier monitoring of activated partial thromboplastin time on the incidence of ischemic and hemorrhagic complications in patients with ST-elevation myocardial infarction treated with full-dose tenecteplase.
J.P. Curtis and colleagues explained, "We compared the outcomes of patients enrolled in the Second Assessment of the Safety and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Albert Einstein College of Medicine
Cryptococcus glucuronoxylomannan IgM have diverse gene use profiles - Alnylam Pharmaceuticals, Inc.
Pharmaceutical company appoints Robert Millman as chief patent counsel - Bristol-Myers Squibb
Settlement awards $11.3 million to U.S. government for Medicaid expenses - Centers for Medicare & Medicaid Services
Low-income beneficiaries have new ways to save with drug discount cards - Cephalon, Inc.
Pharmaceutical company names VPs to medical affairs and intellectual property - Ceres Group, Inc.
Ceres group announces settlement of class action litigation - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
